Teva Statement on Providing Essential Medicines in Ukraine and Russia
Teva’s primary concern is the health and safety of patients and those affected by the war in Ukraine, and we have been supporting all our impacted employees and their families. As a leading pharmaceutical company and one of the largest manufacturers of generic medicines, we have a responsibility to provide treatments to patients who need them, and we remain committed to doing so in a safe and compliant manner.
Last week, we announced a donation of more than $11 million (wholesale acquisition cost) worth of essential medicines for Ukrainian refugees impacted by the war. This includes approximately 27 million doses of medicines, mostly provided in collaboration with Teva's long-term trusted partner, Direct Relief.
We are monitoring the evolving situation and will adjust our operations as needed to continue getting essential medicines to patients.